Increased dosage of epirubicin and mitomycin-C for the treatment of metastatic adenocarcinoma of unknown primary site.

Source:http://linkedlifedata.com/resource/pubmed/id/16312826

Download in:

View as

Triples

General Info

PMID
16312826